| Symbol | MDIN |
|---|---|
| Name | MEDGEN, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | M5C 1S6 Canada ON 100 Queen St E, Suite 203 |
| Telephone | 647-417-1820 |
| Fax | — |
| — | |
| Website | http://www.medgencorp.com |
| Incorporation | US |
| Incorporated On | 1996 |
| Employees | — |
| Fiscal Year | 9/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | UNAUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001045707 |
| Description | MedGen, Inc. is a MedTech and Lifesciences Company Focused on Technology Commercialization and Investment. The Company operates in Four Segments, including Biomedical, Healthcare, Precision Medicine and Pharmaceutical. MedGen Portfolio Companies, Divisions and Subsidiaries offers a range of Products, Solutions and Services for Sale and Licensing. The First Subsidiary emb3Ded Advanced Technologies, is Additive Manufacturing @ the Micro & Nanoscale with Initial Focus on Biotechnology Utilizing 3D Bioprinting. Producing Consumable Materials and Products that Mimic the Natural Shape of Tissues in the Human Body. The Second Subsidiary, will leverage its Current Patents to Produce Artificial Human Organs (Extracorporeal). Application 1 - Liver Assist Device. Application 2 - Drug Development/ Testing Reducing FDA Rejection. Other Divisions and Products Include: 1. Medical Device Coatings. 2. Smart Bandages. 3. eTextiles. 4. Printed Electronics. Follow MedGen on Twitter @IncMedgen Additional info from OTC: |
No news found.